PPD valued at more than $9bn as investors recapitalize
A new ownership structure at Pharmaceutical Product Development, LLC (PPD) is designed to help drive the company’s next phase of growth.
A new ownership structure at Pharmaceutical Product Development, LLC (PPD) is designed to help drive the company’s next phase of growth.
The Philadelphia-based 'Patient Interaction Center (PIC)' will support patients participating in home-based clinical trials, 24 hours, 7 days a week.
QuintilesIMS has announced an alliance with Salesforce through which the companies aim to “equip and enable” customers to meet future healthcare challenges.